Study of dorzagliatin for early diabetes and high blood sugar
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new pill, dorzagliatin, to see how it affects insulin and blood sugar control in people with early type 2 diabetes or high blood sugar after a sugary drink. It may help improve blood sugar management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 69 years old
- Your body mass index is between 18 and 34.9
- You have either early type 2 diabetes (HbA1c 6.5% to 10%) and may be on metformin, or high blood sugar after a drink (without diabetes)
- You have not used glucose-lowering drugs (except metformin) recently
- You are generally healthy without severe kidney, liver, heart, or blood conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental pill (a glucokinase activator) in adults with a specific genetic form of diabetes called GCK-MODY. The study aims to see if the pill can help control blood sugar without causing dangerously low sugar levels.
This study tests an experimental diabetes pill (dorzagliatin) in people with type 2 diabetes and moderate to severe kidney problems. The goal is to see if it helps keep blood sugar levels stable and is safe for those with reduced kidney function.
This study tests a drug called dorzagliatin to see if it can help control blood sugar in adults with cystic fibrosis who have pancreatic insufficiency and abnormal glucose tolerance.
This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.
This study tests an investigational pill (called cadisegliatin) added to your usual insulin treatment for people with type 1 diabetes who use an automated insulin pump. It aims to improve blood sugar control and reduce the time your sugar is too high.
This study compares two different two-drug combinations for people recently diagnosed with type 2 diabetes. It aims to find which combination works better to control blood sugar and improve overall health.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.